These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36159944)

  • 21. Global opioid agonist treatment: a review of clinical practices by country.
    Jin H; Marshall BDL; Degenhardt L; Strang J; Hickman M; Fiellin DA; Ali R; Bruneau J; Larney S
    Addiction; 2020 Dec; 115(12):2243-2254. PubMed ID: 32289189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of buprenorphine and methadone among opioid users who inject drugs.
    Tsui JI; Burt R; Thiede H; Glick SN
    Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The situation in the German forensic commitment-Results of a survey by the DGPPN].
    Zeidler R; Dudeck M; Frank U; Gerlinger G; Hesse D; Muysers J; Pollmächer T; Riedemann C; Sander J; Völlm B; Müller JL
    Nervenarzt; 2024 Jan; 95(1):1-8. PubMed ID: 37943326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterizing opioid agonist treatment discontinuation trends in British Columbia, Canada, 2012-2018.
    Krebs E; Homayra F; Min JE; MacDonald S; Gold L; Carter C; Nosyk B
    Drug Alcohol Depend; 2021 Aug; 225():108799. PubMed ID: 34087747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survey on the Prescription Patterns of Pharmacological Agents in Individuals Who Have Committed Sexual Offenses During Forensic Outpatient Treatment in Germany: How Many Discontinue Testosterone Lowering Medication Under Parole?
    Sauter J; Rettenberger M; Briken P; Turner D
    J Sex Med; 2022 Jul; 19(7):1147-1155. PubMed ID: 35624071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seasonal variation of seclusion incidents from violent and suicidal acts in forensic psychiatric patients.
    Paavola P; Tiihonen J
    Int J Law Psychiatry; 2010; 33(1):27-34. PubMed ID: 19962761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in opioid agonist therapy in the Veterans Health Administration: is supply keeping up with demand?
    Oliva EM; Trafton JA; Harris AH; Gordon AJ
    Am J Drug Alcohol Abuse; 2013 Mar; 39(2):103-7. PubMed ID: 23421571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study.
    Pearce LA; Min JE; Piske M; Zhou H; Homayra F; Slaunwhite A; Irvine M; McGowan G; Nosyk B
    BMJ; 2020 Mar; 368():m772. PubMed ID: 32234712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions.
    Bouck Z; Scheim AI; Gomes T; Ling V; Caudarella A; Werb D
    Int J Drug Policy; 2022 Jun; 104():103680. PubMed ID: 35447476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial.
    Liebschutz JM; Crooks D; Herman D; Anderson B; Tsui J; Meshesha LZ; Dossabhoy S; Stein M
    JAMA Intern Med; 2014 Aug; 174(8):1369-76. PubMed ID: 25090173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of selection into buprenorphine/naloxone among people initiating opioid agonist treatment in British Columbia.
    Homayra F; Hongdilokkul N; Piske M; Pearce LA; Zhou H; Min JE; Krebs E; Nosyk B
    Drug Alcohol Depend; 2020 Feb; 207():107798. PubMed ID: 31927163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One size does not fit all-evolution of opioid agonist treatments in a naturalistic setting over 23 years.
    Nordt C; Vogel M; Dey M; Moldovanyi A; Beck T; Berthel T; Walter M; Seifritz E; Dürsteler KM; Herdener M
    Addiction; 2019 Jan; 114(1):103-111. PubMed ID: 30209840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged-release opioid agonist therapy: qualitative study exploring patients' views of 1-week, 1-month, and 6-month buprenorphine formulations.
    Neale J; Tompkins CNE; Strang J
    Harm Reduct J; 2019 Apr; 16(1):25. PubMed ID: 30943990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Criminal Recidivism After Forensic Psychiatric Treatment. A Multicenter Study on the Role of Pretreatment, Treatment-Related, and Follow-Up Variables.
    Probst T; Bezzel A; Hochstadt M; Pieh C; Mache W
    J Forensic Sci; 2020 Jul; 65(4):1221-1224. PubMed ID: 31961952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interim opioid agonist treatment for opioid addiction: a systematic review.
    Samsó Jofra L; Puig T; Solà I; Trujols J
    Harm Reduct J; 2022 Jan; 19(1):7. PubMed ID: 35090475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substitution treatment for opioid dependence with slow-release oral morphine: Retention rate, health status, and substance use after switching to morphine.
    Lehmann K; Kuhn S; Baschirotto C; Jacobsen B; Walcher S; Görne H; Backmund M; Scherbaum N; Reimer J; Verthein U
    J Subst Abuse Treat; 2021 Aug; 127():108350. PubMed ID: 34134867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant Heroin and Cocaine Use among Opioid-Dependent Patients during Methadone, Buprenorphine or Morphine Opioid Agonist Therapy.
    Gastberger S; Baumgartner MR; Soyka M; Quednow BB; Hulka LM; Herdener M; Seifritz E; Mutschler J
    Eur Addict Res; 2019; 25(4):207-212. PubMed ID: 31067528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short term health-related quality of life improvement during opioid agonist treatment.
    Nosyk B; Bray JW; Wittenberg E; Aden B; Eggman AA; Weiss RD; Potter J; Ang A; Hser YI; Ling W; Schackman BR
    Drug Alcohol Depend; 2015 Dec; 157():121-8. PubMed ID: 26511766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of treatment retention rates and predictors of retention on opioid agonist treatment among adolescents.
    Shakya P; Jangra J; Rao R; Mishra AK; Bhad R
    Drug Alcohol Rev; 2024 Jun; ():. PubMed ID: 38884374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.
    Bonhomme J; Shim RS; Gooden R; Tyus D; Rust G
    J Natl Med Assoc; 2012; 104(7-8):342-50. PubMed ID: 23092049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.